According to the European Society for Immunodeficiencies (ESIDs) criteria, CVID is characterized by a marked reduction in immunoglobulin IgG and IgA with or without reduced IgM levels, as well as reduced frequencies of switched memory B cells and/or diminished vaccine antibody responses [4,5]. The gene discussed is CD40LG; the disease is common variable immunodeficiency.